A recent study shows that PAD4 inhibitors prevent NET formation in sepsis and tumor models (31, 32), and PAD4-deficient neutrophils lose the ability to release NETs after stimulation with LPS and tumor necrosis factor (33). This evidence concerns the gene PADI4 and neoplasm.